Windlas Biotech (WINDLAS.NS) Stock Price
Windlas Biotech Price
Revenue has compounded at 12.5% per year over the past 8 years to 9.04 B INR. Earnings per share have grown at 24.9% per year over the last 8 years. Windlas Biotech's net margin stands at 7.4%, broadly stable from 8.2% several years earlier. Windlas Biotech currently offers a dividend yield of about 0.60%. The payout ratio is around 20% of earnings. The dividend has grown at 13.5% per year over the past 4 years.
Windlas Biotech stock price
Windlas Biotech business model & stock analysis
Frequently asked questions about Windlas Biotech
Converted at the current exchange rate, the Windlas Biotech share trades at 8.93 EUR (967.60 INR).
The revenue of Windlas Biotech is 9.04 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Windlas Biotech is 664.56 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Windlas Biotech is currently 30.89. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Windlas Biotech stock.
The price-to-sales ratio (P/S) of Windlas Biotech is currently 2.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Windlas Biotech stock.
The Eulerpool Quality Score for Windlas Biotech is 4/10.
The ISIN of Windlas Biotech is INE0H5O01029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Windlas Biotech is WINDLAS.NS. The ticker symbol is used to trade Windlas Biotech shares on the stock exchange.
Windlas Biotech stock
Windlas Biotech Peer Group
Windlas Biotech FIGI
All fundamentals and in-depth analysis of Windlas Biotech
Our stock analysis for Windlas Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Windlas Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.